Summary
Previous studies demonstrated that the immunohistochemical expression of thymidine phosphorylase (dThdPase) was related with distant metastasis and disease progression. In this study we investigated the production of dThdPase/platelet-derived endothelial cell growth factor in gastric cancer quantitatively. In a total of 75 tumour tissues and 60 normal gastric mucosa specimens, dThdPase protein concentrations were determined by ELISA. The amount of dThdPase was significantly higher in the tumour tissue than in the normal tissue. Intratumoural dThdPase concentrations were significantly higher in Borrmann types I and II macroscopically, in poorly differentiated and solid type histologically, in the medullary type of the tumour stroma, and in the tumour-invading serosa. In the medullary type of the amount of tumour stroma, protein levels of dThdPase were positively correlated with the vertical diameter of the tumour (r = 0.580, P = 0.019). By immunohistochemical study, dThdPase expression on tumour cells was observed in all seven specimens with high dThdPase protein levels, but not in all 14 cases with low dThdPase protein levels (P < 0.05). In summary, these data indicated that dThdPase is up-regulated in advanced solid types of gastric cancer, suggesting that dThdPase production in carcinoma cells might be induced by the microenvironment.
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Cook, A. F., Holman, M. J., Kramer, M. J. & Trown, P. W. (1979). Fluorinated pyrimidine nucleoside. 3. Synthesis and antitumor activity of a series of 5′-deoxy-5-fluoropyrimidine nucleosides. J Med Chem, 22: 1330–1335.
Eda, H., Fujimoto, K., Watanabe, S., Ura, M., Ura, M., Hino, A., Tanaka, Y., Wada, K. & Ishitsuka, H. (1993). Cytokines induce thymidine phosphorylase expression in tumour cells and make them more susceptible to 5′-deoxy-5-fluorouridine. Cancer Chemother Pharmacol, 32: 333–338.
Folkman, J. (1990). What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 82: 4–6.
Folkman, J. & Klagsbrun, M. (1987). Angiogenic factors. Science, 235: 442–447.
Fox, S. B., Westwood, M., Moghaddam, A., Comley, M., Turley, H., Whitehouse, R. M., Bicknell, R., Gatter, K. C. & Harris, A. L. (1996). The angiogenic factor, platelet derived endothelial cell growth factor thymidine phosphorylase is up-regulated in breast cancer epithelium and endothelium. Br J Cancer, 73: 275–280.
Furukawa, T., Yoshimura, A., Sumizawa, T., Haraguchi, M. & Akiyama, S. (1992). Angiogenic factor. Nature, 356: 668
Griffiths, L. & Stratford, I. J. (1997). Platelet-derived endothelial cell growth factor thymidine phosphorylase in tumor growth and response to therapy. Br J Cancer, 76: 689–693.
Griffiths, L., Dachs, G., Bicknell, R., Harris, A. L. & Stratford, I. J. (1997). The influence of oxygen tension and pH on the expression of platelet-derived endothelial cell growth factor/thymidine phosphorylase in human breast tumor cells grown in vitro and in vivo. Cancer Res 57: 570–572.
Ishikawa, F., Miyazono, K., Hellmen, U., Drexler, H., Wernstedt, C., Hagiwara, K., Usuki, K., Takaku, E., Risau, W. & Heldin, C-H (1989). Identification of angiogenic activity and the cloning and expression of platelet-derived endothelial cell growth factor. Nature, 338: 557–562.
Ishitsuka, H., Miwa, M., Takemoto, K., Fukuoka, K., Itoga, A. & Maruyama, H. D. (1980). Role of uridine phosphorylase for anti-tumor activity of 5′-deoxy-5-fluorouridine. Gann, 71: 112–123.
Japanese Research Society for Gastric Cancer (1995). Japanese Classification of Gastric Carcinoma, First English Edition, Kanehara: Tokyo
Kito, T., Yamada, E., Miyaishi, S., Nakazato, H., Kato, H., Takagi, M., Yasue, T., Kato, T., Morimoto, S., Yamauchi, S., Suchi, T., Sato, C. & Suzuki, R. (1981). Prognosis and pathological type in advanced gastric cancer (in Japanese). Geka, 43: 1041–1046.
Kono, A., Hara, Y., Sugata, S., Karube, Y., Matsushima, Y. & Ishituka, H. (1983). Activation of 5′-deoxy-5-fluorouridine by thymidine phosphorylase in human tumors. Chem Pharm Bull Tokyo 31: 175–178.
Maeda, K., Chung, Y. S., Ogawa, Y., Ogawa, Y., Takatsuka, S., Kang, S. M., Ogawa, M., Sawada, T., Onoda, N., Kato, Y. & Sowa, M. (1996). Thymidine phosphorylase/platelet-derived endothelial cell growth factor expression associated with hepatic metastasis in gastric carcinoma. Br J Cancer, 73: 884–888.
Miwa, M., Nishimura, J., Kamiyama, T. & Ishitsuka, H. (1987). Conversion of 5′-deoxy-5-fluorouridine to 5-FU by pyrimidine nucleoside phosphorylases in normal and tumor tissues from rodents bearing tumors and cancer patients. Jpn J Cancer Res, 14: 2924–2929.
Miyazono, K., Okabe, T., Urabe, A., Takaku, F. & Heldin, C. H. (1987). Purification and properties of an endothelial cell growth factor from human platelets. J Biol Chem, 262: 4098–4103.
Nio, Y., Kimura, H., Tsubono, M., Tseng, C. C., Kawabata, K., Masai, Y., Hayashi, H., Meyer, C., Fukumoto, M. & Tobe, T. (1992). Anti-tumor activity of 5′-deoxy-5-fluorouridine in human digestive organ cancer xenografts and pyrimidine nucleoside phosphorylase activity in normal and neoplastic tissues from human digestive organs. Anticancer Res, 12: 1141–1146.
Nishida, M., Hino, A., Kazushige, M., Matsumoto, T., Yoshikubo, T. & Ishitsuka, H. (1996). Preparation of anti-human thymidine phosphorylase monoclonal antibodies useful for detecting the enzyme levels in tumor tissues. Biol Pharm Bull, 19: 1407–1411.
Takebayashi, Y., Miyadera, K., Akiyama, S., Hokita, S., Yamada, K., Akiba, S., Yamada, Y., Sumizawa, T. & Aikou, T. (1996a). Expression of thymidine phosphorylase in human gastric carcinoma. Jpn J Cancer Res, 87: 288–295.
Takebayashi, Y., Yamada, K., Miyadera, K., Sumizawa, T., Furukawa, T., Kinoshita, E., Aoki, D., Okimura, H., Yamada, Y., Akiyama, S. & Aikou, T. (1996b). The activity and expression of thymidine phosphorylase in human solid tumors. Eur J Cancer, 32: 1227–1232.
Yoshimura, A., Kuwazuru, Y., Furukawa, T., Yoshida, H., Yamada, K. & Akiyama, S. (1990). Purification and tissue distribution of human thymidine phosphorylase; high expression in lymphocytes, reticulocytes and tumors. Biochim Biophys Acta, 1034: 107–113.
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Yoshikawa, T., Suzuki, K., Kobayashi, O. et al. Thymidine phosphorylase/platelet-derived endothelial cell growth factor is upregulated in advanced solid types of gastric cancer. Br J Cancer 79, 1145–1150 (1999). https://doi.org/10.1038/sj.bjc.6690182
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bjc.6690182
Keywords
This article is cited by
-
Chitosan-Graft-Poly (N-Isopropylacrylamide)Co-Polymer as a Carrier for Targeted Delivery and Enhanced Catalytic Activity of Capecitabine
Topics in Catalysis (2022)
-
Thymidine phosphorylase in cancer cells stimulates human endothelial cell migration and invasion by the secretion of angiogenic factors
British Journal of Cancer (2011)
-
Prognostic value of thymidine phosphorylase activity in liver tissue adjacent to hepatocellular carcinoma
International Journal of Clinical Oncology (2005)